Trasylol Recall: Side Effects, Warnings and Risks

Bayer Pharmaceutical’s anti-bleeding drug Trasylol was permanently removed from the market in 2008. This removal came after several studies showed Trasylol to cause twice as many deaths as similar drugs. The most recent study was published in the New England Journal of Medicine on May 19, 2008.

The FDA (Food and Drug Administration) had issued a prior Trasylol warning on February 8, 2006, alerting doctors to two studies linking the drug to higher risks of serious Trasylol side effects, including kidney failure, heart attacks and strokes. A stronger warning was required for the drug on December 15, 2006, but it was not removed from the market.

Trasylol was commonly used to prevent blood loss during coronary artery bypass graft (CABG), heart valve, and knee and hip replacement surgery.

Check out the following articles for more information about Trasylol, filing a Trasylol lawsuit and finding a Trasylol attorney.